Cargando…

Obstructive sleep apnea and peripheral vascular disease: a systematic review based on current literature

INTRODUCTION: Obstructive sleep apnea (OSA) is an established risk factor for poor cardiovascular outcomes and coronary artery disease, but its influence on the development of peripheral artery disease (PAD) is not well established. The aim of our study was to understand the mutual prevalence of OSA...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahsan, Muhammad Junaid, Latif, Azka, Fazeel, Hafiz Muhammad, Lateef, Noman, Zoraiz Ahsan, Muhammad, Kapoor, Vikas, Batool, Syeda Sabeeka, Mirza, Mohsin, Ashfaq, Zubair, Holmberg, Mark, Anwer, Faiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426973/
https://www.ncbi.nlm.nih.gov/pubmed/32850063
http://dx.doi.org/10.1080/20009666.2020.1764276
Descripción
Sumario:INTRODUCTION: Obstructive sleep apnea (OSA) is an established risk factor for poor cardiovascular outcomes and coronary artery disease, but its influence on the development of peripheral artery disease (PAD) is not well established. The aim of our study was to understand the mutual prevalence of OSA and PAD and any reported statistical association between the two conditions. METHODS: PubMed, Ovid Embase, Web of Science, Cochrane library and clinicaltrials.gov databases were systematically searched up to 29 November 2018. A total of 844 articles were identified and 744 articles were screened for relevance. RESULTS AND CONCLUSION: Eleven prospective cohorts qualified for inclusion with N = 63,642 (M = 28,062, F = 35,494). All studies evaluated OSA severity primarily with apnea–hypopnea index (AHI) values. The overall prevalence of PAD was 20.5% (N = 13,068). Except for two studies, all studies reported an increased prevalence of OSA in patients with PAD. OSA severity was not found to have an association with poor ankle brachial index values or increasing daytime sleepiness as measured by Epworth sleepiness scale. Further prospective clinical trials are required to further delineate this finding.